Actively Recruiting
The Value of 68Ga-FAPI PET/CT in Detecting Recurrent and Metastatic Lesions in Patients with Thyroid Cancer After Surgery
Led by Ruijin Hospital · Updated on 2025-01-30
40
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to investigate the value of 68Ga-FAPI PET/CT in detecting recurrent and metastatic lesions in patients with thyroid cancer after surgery.
CONDITIONS
Official Title
The Value of 68Ga-FAPI PET/CT in Detecting Recurrent and Metastatic Lesions in Patients with Thyroid Cancer After Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with thyroid cancer who have undergone surgery and are suspected of recurrence or metastasis during clinical evaluation
- Signed and dated informed consent form
- Commitment to comply with research procedures and cooperate fully with the study
- Aged 18-80 years old
You will not qualify if you...
- Serious illnesses such as severe heart and lung failure, severe bone marrow suppression, or severe liver and kidney dysfunction
- Intestinal perforation or complete intestinal obstruction
- Pregnant women, women who may be pregnant, or breastfeeding women
- Persons who are non-compliant with study requirements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine
Shanghai, Shanghai Municipality, China, 200001
Actively Recruiting
Research Team
J
Jiajia Hu
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here